Vivo Bio Tech Holds 39th AGM, Re-appointment of Directors Discussed

Vivo Bio Tech Ltd held its 39th Annual General Meeting (AGM) on September 30, 2026, via Video Conference (VC)/Other Audio-Visual Means (OAVM). The meeting was conducted in compliance with relevant circulars and provisions of the Companies Act, 2013. Key agenda items included the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, the re-appointment of Mr. Kalyan Ram Mangipudi, Mr. Sri Kalyan Kompella, and Dr. Sankaranarayanan Alangudi as Whole-time Directors. The company also confirmed that its ESOP Schemes were implemented in accordance with SEBI Regulations. Remote e-voting facilities were provided for all agenda items.